CD8+ cells from patient peripheral blood, matched adjacent kidney tissue, and RCC TILs were cultured in IL-7 to maintain viability in an unstimulated state, stimulated with anti-CD3 to stimulate the T cell receptor alone, or treated with anti-CD3 in combination with anti-CD28. The gene discussed is CD8A; the disease is renal cell carcinoma.